Skip to main content

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

UBX holding history

Unity Biotechnology, Inc. in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UBX overviewAll 13F holders of UBXFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of UBX by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−45−100.0%Sold outHolders
Q2 202345$115<0.1%00.0%UnchangedHolders
Q1 202345$74<0.1%00.0%UnchangedHolders
Q4 202245$123<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q3 2022450$00.0%00.0%UnchangedHolders
Q2 2022450$00.0%00.0%UnchangedHolders
Q1 2022450$1.00K<0.1%00.0%UnchangedHolders
Q4 2021450$1.00K<0.1%00.0%UnchangedHolders
Q3 2021450$1.00K<0.1%00.0%UnchangedHolders
Q2 2021450$2.00K<0.1%00.0%UnchangedHolders
Q1 2021450$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.